Kura Oncology, Inc. (KURA) has a market capitalization of $807.33M and trades at $9.14. The 52-week range is 5.41-12.49.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.9, Earnings Per Share (EPS) of $-3.18, annual revenue of $67.48M.
The stock has a beta of 0.24, operates in the Healthcare sector.
